Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Allurion Technologies Inc
ALUR
Alternate Symbol(s):
ALUR.WS
Healthcare
Medical Devices
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video...
telehealth that are delivered by the Allurion Virtual Care Suite. The company operates in Spain, France, Turkey, and internationally. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NYSE:ALUR)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 06, 2025 3:02pm
ALUR....Now that the "dust has settled" and all the....
Chasers & FOMO's are buried with high priced paper...... I'm here to bring calm to the masses. Might be a good time to start a position since it is "Fryday"....last at $2.66
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 26, 2025 8:02am
New Press Release - Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced its financial results for the fourth quarter and full year ended December 31, 2024 and provided a business update. Recent Company Highlights and Outlook Reported initial...
read article.
(229)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Mar 21, 2025 9:16am
Buy buddy buy because it's taking off this morning.
Otherwise you guys will be missing the boat and big money
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 20, 2025 4:07pm
New Press Release - Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence
Average Total Weight Loss of 20% With 15% Increase in Lean Body Mass After 8 Months of Combined Therapy Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced initial results on the combination of the Allurion Program with...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 12, 2025 4:05pm
New Press Release - Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025
Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will report financial results for the fourth quarter 2024 on Wednesday, March 26, 2025. Company management will host a conference call to discuss financial...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 04, 2025 4:05pm
New Press Release - Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity
Patent portfolio now exceeds 60 issued patents globally Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has received two Issue Notifications from the U.S. Patent and Trademark Office (USPTO) dated February 19...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 25, 2025 4:05pm
New Press Release - Allurion to Participate in Upcoming Investor Conferences
Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will be participating in two upcoming investor conferences. Dr. Shantanu Gaur, Founder and Chief Executive Officer, will present at 9:10 a.m. ET and host one-on...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 20, 2025 4:07pm
New Press Release - Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline
Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has closed its previously announced registered direct offering with institutional investors for the purchase and sale of 900,000 shares of the Company’s common...
read article.
(229)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Feb 19, 2025 10:30am
Sell buddy sell.
You guys are going down today
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 19, 2025 9:13am
New Press Release - Allurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline
Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has entered into a definitive securities purchase agreement with certain institutional investors for the purchase and sale of 900,000 shares of the Company’s...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 18, 2025 8:32am
New Press Release - Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity
Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced its intention to initiate a clinical study on the combination of the Allurion Balloon with GLP-1 agonists. The study will focus on combination use of the Allurion Balloon...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 13, 2025 8:34am
New Press Release - Allurion Relaunches in France
ANSM, the French regulatory authority, clears Allurion to resume sales of the Allurion BalloonCompany considering sites in France for clinical trial on combination therapy of Allurion Balloon and GLP-1s to prevent muscle loss Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR...
read article.
(229)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jan 27, 2025 4:19pm
It is complicated to try to figure out
Because of the market manipulators at work today.
(229)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jan 27, 2025 7:18am
Sell buddy sell.Wow.
Otherwise you guys will be left holding the bag.
(30)
•••
thedave2006
X
Post by
thedave2006
on Jan 24, 2025 11:12am
biotech hot
take care in the volatility
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Sorrento Resources Provides Update on Exploration on Rodgers Cove Project, Newfoundland
A tungsten producer and developer in Portugal, South Korea & Spain on track to become a top supplier
DiagnosTear Announces Clinical Study to Advance Analytical Validation & FDA Submission Pathway of TeaRx(TM)
A Company Focused on Developing Functional Healthier “Better For You” Foods
Building Momentum in One of the World's Most Prospective Copper Regions